BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 10570264)

  • 21. FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand.
    Kalas W; Matuszyk J; Ziolo E; Strzadala L
    Anticancer Res; 2003; 23(2B):1613-7. PubMed ID: 12820430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific induction of RGS16 (regulator of G-protein signalling 16) mRNA by protein kinase C in CEM leukaemia cells is mediated via tumour necrosis factor alpha in a calcium-sensitive manner.
    Fong CW; Zhang Y; Neo SY; Lin SC
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):747-53. PubMed ID: 11104682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression.
    Faris M; Kokot N; Latinis K; Kasibhatla S; Green DR; Koretzky GA; Nel A
    J Immunol; 1998 Jan; 160(1):134-44. PubMed ID: 9551965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase C is not a downstream effector of p21ras in activated T cells.
    Williams DH; Woodrow M; Cantrell DA; Murray EJ
    Eur J Immunol; 1995 Jan; 25(1):42-7. PubMed ID: 7843251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AMP-activated protein kinase mediates T cell activation-induced expression of FasL and COX-2 via protein kinase C theta-dependent pathway in human Jurkat T leukemia cells.
    Lee JY; Choi AY; Oh YT; Choe W; Yeo EJ; Ha J; Kang I
    Cell Signal; 2012 Jun; 24(6):1195-207. PubMed ID: 22330070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of phosphatidylinositol turnover is a key event for Fas-dependent, activation-induced apoptosis in human T lymphocytes.
    Izquierdo M; Ruiz-Ruiz MC; López-Rivas A
    J Immunol; 1996 Jul; 157(1):21-8. PubMed ID: 8683117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of fas ligand expression by an acutely lethal simian immunodeficiency virus, SIVsmmPBj14.
    Hodge S; Novembre FJ; Whetter L; Gelbard HA; Dewhurst S
    Virology; 1998 Dec; 252(2):354-63. PubMed ID: 9878614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcineurin activation protects T cells from glucocorticoid-induced apoptosis.
    Zhao Y; Tozawa Y; Iseki R; Mukai M; Iwata M
    J Immunol; 1995 Jun; 154(12):6346-54. PubMed ID: 7539018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma.
    Matsui K; Fine A; Zhu B; Marshak-Rothstein A; Ju ST
    J Immunol; 1998 Oct; 161(7):3469-73. PubMed ID: 9759866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of L-selectin mRNA in Jurkat cells. Opposing influences of calcium- and protein kinase C-dependent signaling pathways.
    Kaldjian EP; Stoolman LM
    J Immunol; 1995 May; 154(9):4351-62. PubMed ID: 7536769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated function.
    Cui H; Sherr DH; el-Khatib M; Matsui K; Panka DJ; Marshak-Rothstein A; Ju ST
    Cell Immunol; 1996 Feb; 167(2):276-84. PubMed ID: 8603437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes.
    Norian LA; Latinis KM; Koretzky GA
    J Immunol; 1998 Aug; 161(3):1078-82. PubMed ID: 9686564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
    Wingett D; Long A; Kelleher D; Magnuson NS
    J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression.
    Wang R; Brunner T; Zhang L; Shi Y
    Oncogene; 1998 Sep; 17(12):1503-8. PubMed ID: 9794227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct requirements for activation-induced cell surface expression of preformed Fas/CD95 ligand and cytolytic granule markers in T cells.
    Kassahn D; Nachbur U; Conus S; Micheau O; Schneider P; Simon HU; Brunner T
    Cell Death Differ; 2009 Jan; 16(1):115-24. PubMed ID: 19079288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement of cell-cell contact in the induction of Jurkat T cell apoptosis: the membrane-anchored but not soluble form of FasL can trigger anti-CD3-induced apoptosis in Jurkat T cells.
    Oyaizu N; Kayagaki N; Yagita H; Pahwa S; Ikawa Y
    Biochem Biophys Res Commun; 1997 Sep; 238(2):670-5. PubMed ID: 9299572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription.
    Srivastava RK; Sasaki CY; Hardwick JM; Longo DL
    J Exp Med; 1999 Jul; 190(2):253-65. PubMed ID: 10432288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Requirement of a second signal via protein kinase C or protein kinase A for maximal expression of CD40 ligand. Involvement of transcriptional and posttranscriptional mechanisms.
    Suárez A; Mozo L; Gayo A; Zamorano J; Gutierrez C
    Eur J Immunol; 1997 Nov; 27(11):2822-9. PubMed ID: 9394805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells.
    Chwae YJ; Chang MJ; Park SM; Yoon H; Park HJ; Kim SJ; Kim J
    J Immunol; 2002 Oct; 169(7):3726-35. PubMed ID: 12244166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signal requirements for interleukin 4 promoter activation in human T cells.
    Paliogianni F; Hama N; Mavrothalassitis GJ; Thyphronitis G; Boumpas DT
    Cell Immunol; 1996 Feb; 168(1):33-8. PubMed ID: 8599837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.